Cayssials, E., Torregrosa‐Diaz, J., Gallego‐Hernanz, P., Tartarin, F., Systchenko, T., Maillard, N., Desmier, D., Machet, A., Fleck, E., Corby, A., Motard, C., Denis, G., Herbelin, A., Gombert, J., Roy, L., Ragot, S., Leleu, X., Guilhot, F., & Chomel, J. (2020). low‐dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment‐free remission in chronic myeloid leukemia patients: Results of a retrospective study. Cancer, 126(15), 3438–3447. http://access.bl.uk/ark:/81055/vdc_100103803089.0x000062